153 related articles for article (PubMed ID: 22797812)
1. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
Banno K; Yanokura M; Kawaguchi M; Kuwabara Y; Akiyoshi J; Kobayashi Y; Iwata T; Hirasawa A; Fujii T; Susumu N; Tsukazaki K; Aoki D
Int J Oncol; 2007 Oct; 31(4):713-20. PubMed ID: 17786301
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer.
Wang L; Xie L; Wang J; Shen J; Liu B
BMC Gastroenterol; 2013 Dec; 13():173. PubMed ID: 24359226
[TBL] [Abstract][Full Text] [Related]
5. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
Patro BS; Frøhlich R; Bohr VA; Stevnsner T
J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
[TBL] [Abstract][Full Text] [Related]
6. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
[TBL] [Abstract][Full Text] [Related]
8. WRN counteracts the NHEJ pathway upon camptothecin exposure.
Otsuki M; Seki M; Kawabe Y; Inoue E; Dong YP; Abe T; Kato G; Yoshimura A; Tada S; Enomoto T
Biochem Biophys Res Commun; 2007 Apr; 355(2):477-82. PubMed ID: 17303082
[TBL] [Abstract][Full Text] [Related]
9. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase.
Futami K; Takagi M; Shimamoto A; Sugimoto M; Furuichi Y
Biol Pharm Bull; 2007 Oct; 30(10):1958-61. PubMed ID: 17917271
[TBL] [Abstract][Full Text] [Related]
10. Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.
Chun SG; Yee NS
Cancer Biol Ther; 2010 Sep; 10(5):430-7. PubMed ID: 20657174
[TBL] [Abstract][Full Text] [Related]
11. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.
Aggarwal M; Sommers JA; Shoemaker RH; Brosh RM
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1525-30. PubMed ID: 21220316
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].
Wang L; Shen J; Meng LJ; Fan WF; Wang J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):418-22. PubMed ID: 24119900
[TBL] [Abstract][Full Text] [Related]
14. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.
Bosch LJ; Luo Y; Lao VV; Snaebjornsson P; Trooskens G; Vlassenbroeck I; Mongera S; Tang W; Welcsh P; Herman JG; Koopman M; Nagtegaal ID; Punt CJ; van Criekinge W; Meijer GA; Monnat RJ; Carvalho B; Grady WM
Clin Cancer Res; 2016 Sep; 22(18):4612-22. PubMed ID: 27121793
[TBL] [Abstract][Full Text] [Related]
15. WRN helicase defective in the premature aging disorder Werner syndrome genetically interacts with topoisomerase 3 and restores the top3 slow growth phenotype of sgs1 top3.
Aggarwal M; Brosh RM
Aging (Albany NY); 2009 Feb; 1(2):219-33. PubMed ID: 20157511
[TBL] [Abstract][Full Text] [Related]
16. WRN translocation from nucleolus to nucleoplasm is regulated by SIRT1 and required for DNA repair and the development of chemoresistance.
Lee SY; Lee H; Kim ES; Park S; Lee J; Ahn B
Mutat Res; 2015 Apr; 774():40-8. PubMed ID: 25801465
[TBL] [Abstract][Full Text] [Related]
17. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells.
Futami K; Ishikawa Y; Goto M; Furuichi Y; Sugimoto M
Cancer Sci; 2008 May; 99(5):843-8. PubMed ID: 18312465
[TBL] [Abstract][Full Text] [Related]
18. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
19. Role for the Werner syndrome protein in the promotion of tumor cell growth.
Opresko PL; Calvo JP; von Kobbe C
Mech Ageing Dev; 2007; 128(7-8):423-36. PubMed ID: 17624410
[TBL] [Abstract][Full Text] [Related]
20. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration.
Turaga RV; Massip L; Chavez A; Johnson FB; Lebel M
Aging Cell; 2007 Aug; 6(4):471-81. PubMed ID: 17521388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]